NCT02012959 Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia Status TERMINATED Phase PHASE3
NCT01991561 Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. Status COMPLETED Phase PHASE2
NCT01919697 Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Status COMPLETED Phase PHASE3
NCT01919554 Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents Status COMPLETED Phase PHASE1
NCT01803308 A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection Status COMPLETED Phase PHASE1
NCT01798121 Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2) Status UNKNOWN Phase PHASE2
NCT01775189 A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted Status COMPLETED Phase PHASE1
NCT01746901 A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers Status COMPLETED Phase PHASE1
NCT01716975 Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Status COMPLETED Phase PHASE3
NCT01714713 A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Status COMPLETED Phase PHASE3
NCT01714661 Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Status COMPLETED Phase PHASE3
NCT01714037 A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC] Status TERMINATED Phase PHASE1
NCT01689831 Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose) Status UNKNOWN Phase PHASE2
NCT01513967 A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01405950 Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy Status TERMINATED Phase PHASE1
NCT01388933 A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease Status TERMINATED Phase PHASE2
NCT01383096 Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01258816 The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055) Status COMPLETED Phase PHASE1